Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction (CAPRI)
Primary Purpose
ST-segment Elevation Myocardial Infarction
Status
Completed
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
PPCI plus RIPC
PPCI only
Sponsored by
About this trial
This is an interventional treatment trial for ST-segment Elevation Myocardial Infarction focused on measuring ST-segment elevation myocardial infarction, Remote ischemic perconditioning, Primary percutaneous coronary intervention, Cardiac magnetic resonance
Eligibility Criteria
Inclusion Criteria:
- Age >19 years
- Presenting within 12 hours of symptom onset
- >20 min of chest pain
- ST-elevation myocardial infarction defined as ST-segment elevation (>0.1 mV) in at least 2 contiguous precordial leads
Exclusion Criteria:
- Previous myocardial infarction
- Presence of chronic total occlusion
- Evidence of retrograde filling by collaterals at coronary angiography (Rentrop 2 or 3 collateral flow)
- Severe multi-vessel coronary artery disease to require further interventions before follow-up CMR
- Cardiac arrest before randomization
- Arrhythmias requiring external electric shock before randomization
- Unwillingness to participate
- External electric shock for cardioversion within first 3 days
- Cardiac surgery within first 3 days
Sites / Locations
- Wonju Severance Christian Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Sham Comparator
Arm Label
PPCI plus RIPC
PPCI only
Arm Description
The patients randomized to PPCI plus RIPC group will receive RIPC during PPCI.
The patients randomized to PPCI only group will receive PPCI only but the sham procedure of RIPC.
Outcomes
Primary Outcome Measures
Infarct size measured by contrast-enhanced cardiac magnetic resonance
Infarct size will be assessed on late-contrast images (≈10 min after gadolinium administration) by manually tracing the hyperintense area in each short-axis slice.
Secondary Outcome Measures
Enzymatic Infarct Size
Enzymatic infarct size will be assessed by the area under the curve of creatine kinase-myocardial band (CK-MB) and troponin I (TnI) release. Blood samples will be collected before PCI and every day after index PPCI. Area under the curve of CK-MB and troponin I release will be expressed in arbitrary units and calculated with the trapezoidal method.
Resolution of ST-segment deviation
ST-segment deviation score will be measured in 12-lead electrocardiograms, calculated as the sum (in millimeters) of ST-segment deviation (elevation or depression) at 80 ms after the J-point in all 12 leads. ST-segment deviation score will be measured at presentation and 30 min after PCI, by 2 physicians blinded as to the patients' data, and the mean value of the 2 assessments will be used. ST-segment resolution will be calculated as a percentage: ratio of the reduction in ST-segment deviation score from presentation to half an hour after PCI over the ST-segment deviation score at presentation × 100% (i.e., [(ST-segment deviation at presentation - ST-segment deviation post-PCI)/ST-segment deviation at presentation] × 100%). Full ST-segment resolution will be defined as 80% or more reduction of ST-segment deviation score.
Acute kidney injury
Acute kidney injury will be defined as an absolute increase in serum creatinine of ≥0.5 mg/dl or a relative increase of ≥25% compared with baseline within 96 h after PCI (the maximal measured concentration of serum creatinine during these 96 h will be used). Relative reduction in estimated glomerular filtration rate (eGFR), calculated with the Modification of Diet in Renal Disease formula, within 96 h after PCI will be assessed.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02164695
Brief Title
Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction
Acronym
CAPRI
Official Title
Cardioprotective Effects of Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
Study Type
Interventional
2. Study Status
Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
January 31, 2015 (Actual)
Primary Completion Date
July 31, 2017 (Actual)
Study Completion Date
January 31, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Yonsei University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
To evaluate whether remote ischemic per-conditioning (RIPC) can reduce infarct size in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention (PPCI) within 12 hours of symptoms onset.
Control group: PPCI only
Study group: PPCI + RIPC
Primary endpoint: Infarct size measured by contrast-enhanced cardiac magnetic resonance (CMR) at 6 months after the index procedure
Detailed Description
ST-elevation myocardial infarction (STEMI) is a leading cause of mortality and morbidity. Early myocardial reperfusion with either of thrombolytic therapy or primary percutaneous coronary intervention (PPCI) is the most effective strategy for reducing the size of a myocardial infarct and improving the clinical outcome. Although this process can restore blood flow to the ischemic myocardium, it can induce injury. This phenomenon termed myocardial reperfusion injury can paradoxically reduce the beneficial effects of myocardial reperfusion. The pre-clinical study in animal models of acute myocardial infarction suggests that lethal reperfusion injury accounts for up to 50% of the final size of a myocardial infarct.
Remote ischemic conditioning uses brief ischemia and reperfusion of a distant organ to protect the myocardium. In animal study, remote ischemic postconditioning seems to be more effective than local postconditioning in experimental myocardial infarction.Bøtker et al. has reported remote ischemic preconditioning before hospital admission increase myocardial salvage in patients with acute myocardial infarction.
The objective of this study is to evaluate whether remote ischemic per-conditioning (RIPC) can reduce late infarct size in patients with STEMI treated with PPCI within 12 hours of symptoms onset. To test this hypothesis, we will randomize patients into PPCI + RIPC or PPCI alone. We will evaluate marker of reperfusion injury using contrast cardiac magnetic resonance image.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
ST-segment Elevation Myocardial Infarction
Keywords
ST-segment elevation myocardial infarction, Remote ischemic perconditioning, Primary percutaneous coronary intervention, Cardiac magnetic resonance
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Control group: PPCI only
Study group: PPCI + RIPC
Masking
Outcomes Assessor
Masking Description
CMR results will be interpreted by observers blinded to randomization
Allocation
Randomized
Enrollment
118 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PPCI plus RIPC
Arm Type
Active Comparator
Arm Description
The patients randomized to PPCI plus RIPC group will receive RIPC during PPCI.
Arm Title
PPCI only
Arm Type
Sham Comparator
Arm Description
The patients randomized to PPCI only group will receive PPCI only but the sham procedure of RIPC.
Intervention Type
Procedure
Intervention Name(s)
PPCI plus RIPC
Intervention Description
All patients will be prepared with an upper-arm blood pressure cuff before arterial puncture (contralateral in case of radial access). In patients allocated into PPCI plus RIPC group, the protocol will be started immediately after cuff preparation. Upper-arm will be exposed to 4 cycles of ischemia/reperfusion, each obtained by 5 min cuff inflation at 200mmHg, followed by 5 min complete deflation.
Intervention Type
Procedure
Intervention Name(s)
PPCI only
Intervention Description
All patients randomized to PPCI only arm, the blood pressure cuff will be applied to the arm or the calf but will not be inflated.
Primary Outcome Measure Information:
Title
Infarct size measured by contrast-enhanced cardiac magnetic resonance
Description
Infarct size will be assessed on late-contrast images (≈10 min after gadolinium administration) by manually tracing the hyperintense area in each short-axis slice.
Time Frame
6 months after index procedure
Secondary Outcome Measure Information:
Title
Enzymatic Infarct Size
Description
Enzymatic infarct size will be assessed by the area under the curve of creatine kinase-myocardial band (CK-MB) and troponin I (TnI) release. Blood samples will be collected before PCI and every day after index PPCI. Area under the curve of CK-MB and troponin I release will be expressed in arbitrary units and calculated with the trapezoidal method.
Time Frame
1 to 5 days after index procedure
Title
Resolution of ST-segment deviation
Description
ST-segment deviation score will be measured in 12-lead electrocardiograms, calculated as the sum (in millimeters) of ST-segment deviation (elevation or depression) at 80 ms after the J-point in all 12 leads. ST-segment deviation score will be measured at presentation and 30 min after PCI, by 2 physicians blinded as to the patients' data, and the mean value of the 2 assessments will be used. ST-segment resolution will be calculated as a percentage: ratio of the reduction in ST-segment deviation score from presentation to half an hour after PCI over the ST-segment deviation score at presentation × 100% (i.e., [(ST-segment deviation at presentation - ST-segment deviation post-PCI)/ST-segment deviation at presentation] × 100%). Full ST-segment resolution will be defined as 80% or more reduction of ST-segment deviation score.
Time Frame
1 to 5 days after index procedure
Title
Acute kidney injury
Description
Acute kidney injury will be defined as an absolute increase in serum creatinine of ≥0.5 mg/dl or a relative increase of ≥25% compared with baseline within 96 h after PCI (the maximal measured concentration of serum creatinine during these 96 h will be used). Relative reduction in estimated glomerular filtration rate (eGFR), calculated with the Modification of Diet in Renal Disease formula, within 96 h after PCI will be assessed.
Time Frame
1 to 3 days after index procedure
10. Eligibility
Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age >19 years
Presenting within 12 hours of symptom onset
>20 min of chest pain
ST-elevation myocardial infarction defined as ST-segment elevation (>0.1 mV) in at least 2 contiguous precordial leads
Exclusion Criteria:
Previous myocardial infarction
Presence of chronic total occlusion
Evidence of retrograde filling by collaterals at coronary angiography (Rentrop 2 or 3 collateral flow)
Severe multi-vessel coronary artery disease to require further interventions before follow-up CMR
Cardiac arrest before randomization
Arrhythmias requiring external electric shock before randomization
Unwillingness to participate
External electric shock for cardioversion within first 3 days
Cardiac surgery within first 3 days
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Young Jin Youn, MD
Organizational Affiliation
Yonsei Univeristy Wonju College of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Wonju Severance Christian Hospital
City
Wonju
State/Province
Gangwon
ZIP/Postal Code
220060
Country
Korea, Republic of
12. IPD Sharing Statement
Learn more about this trial
Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction
We'll reach out to this number within 24 hrs